Skip to main content
MedPathMedPath Home
Clinical Trials/CTRI/2015/07/006013
CTRI/2015/07/006013
Not yet recruiting
未知

A clinical study to determine the blood glucose response of a dietary fiber on high Glycemic index food and satiety response of a dietary fiber in healthy volunteers.

Mr Ajay Nilawar0 sites32 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Mr Ajay Nilawar
Enrollment
32
Status
Not yet recruiting
Last Updated
4 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional

Investigators

Sponsor
Mr Ajay Nilawar

Eligibility Criteria

Inclusion Criteria

  • •1\.Males or females in the age 18\- 65 years (both inclusive).
  • •2\.Be of normal health as determined by the investigator from medical history, clinical and physical examination.
  • •3\.Random blood sugar level \<\= 200 mg/dl at screening.
  • •4\.BMI between 18\.5 to 27 kg/m2 (both inclusive).
  • •5\.Must be willing to or likely to comply with all study requirements.
  • •6\.Must be able and willing to provide written informed consent.
  • •7\.Women of childbearing potential should have a negative pregnancy test at the time of screening and agree to use contraception during the study.

Exclusion Criteria

  • •1\.Previous history of any clinically significant medical condition e.g. cardiovascular, type 2 diabetes mellitus, eating disorder or serious gastrointestinal indications which in opinion of investigator may jeopardize subjectâ??s safety and preclude trial participation.
  • •2\.Suffering from any condition which may interfere with nutrient absorption, distribution, metabolism and excretion in opinion of the Investigator e.g. subacute obstruction.
  • •3\.Current use of medication which may interfere with the digestion and nutrient absorption or affect glucose tolerance and estimation in opinion of the Investigator.
  • •4\.Abuse of drugs or alcohol.
  • •5\.Known case of sensitivity to Gluten or Coeliac disease.
  • •6\.Pregnant or lactating women.
  • •7\.Currently participating or had participated in any other interventional study in last 1 month prior to screening.
  • •8\.Patients who are unlikely to comply with protocol requirements (e.g. non\-cooperative behavior, illiterate, inability to attend study visits required by the protocol).

Outcomes

Primary Outcomes

Not specified

Similar Trials

Not yet recruiting
Not Applicable
A clinical study to determine the blood glucose response in healthy volunteers
CTRI/2018/06/014355Signutra Inc
Completed
Not Applicable
An investigation study of measuring the glycemic index (GI): non-randomized single administration studyHealthy Japanese subjects
JPRN-UMIN000034551ORTHOMEDICO Inc.11
Completed
Not Applicable
A verification study of the blood glucose response
JPRN-UMIN000052111ORTHOMEDICO Inc.10
Recruiting
Phase 4
A trial investigating the effect on blood glucose after the injection of fast-acting insulin aspart (Fiasp®) in comparison to insulin aspart (NovoRapid®) around exercise in participants with type 1 diabetesE10Type 1 diabetes mellitus
DRKS00015855Forschungseinheit für interdisziplinäre metabolische Medizin, Medizinische Universität Graz44
Active, not recruiting
Phase 1
A study that investigates the effects of fast-acting insulin (FIASP®) on blood sugars in comparison to a different fast-acting insulin (NovoRapid®) around exercise in participants with type 1 diabetesType 1 DiabetesMedDRA version: 20.1 Level: LLT Classification code 10045228 Term: Type I diabetes mellitus System Organ Class: 100000004861Therapeutic area: Diseases [C] - Nutritional and Metabolic Diseases [C18]
EUCTR2019-001281-14-ATMedical University of Graz44